MT4 and nonpapillary renal cell carcinoma: To further identify the accuracy of RCC‐MT4, both TCGA–ccRCC and JAPAN–KIRC cohorts were divided into high‐risk and low‐risk groups according to median scores (Supporting Information: Figure S8D,E).